These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 29532101

  • 1. Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.
    Paquet M, Gauthé M, Zhang Yin J, Nataf V, Bélissant O, Orcel P, Roux C, Talbot JN, Montravers F.
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1710-1720. PubMed ID: 29532101
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
    Breer S, Brunkhorst T, Beil FT, Peldschus K, Heiland M, Klutmann S, Barvencik F, Zustin J, Gratz KF, Amling M.
    Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia.
    Kato A, Nakamoto Y, Ishimori T, Hayakawa N, Ueda M, Temma T, Sano K, Shimizu Y, Saga T, Togashi K.
    Ann Nucl Med; 2021 Mar; 35(3):397-405. PubMed ID: 33582980
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
    Morgat C, Vélayoudom-Céphise FL, Schwartz P, Guyot M, Gaye D, Vimont D, Schulz J, Mazère J, Nunes ML, Smith D, Hindié E, Fernandez P, Tabarin A.
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 18 F-FDG PET/CT and 68 Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.
    Yu HN, Liu L, Chen QS, He Q, Li YS, Wang Y, Gao S.
    Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic efficiency of 68Ga-DOTANOC PET/CT in patients with suspected tumour-induced osteomalacia.
    He Q, Zhang B, Zhang L, Chen Z, Shi X, Yi C, Wang X, Zhang X.
    Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of 99mTc-HYNIC-TOC SPECT/CT for detecting osteomalacia-associated tumors.
    Li B, Duan L, Li X, Shi J, Li H, Liu H, Cheng X, Wu X, Gao Y.
    Front Oncol; 2023 Apr; 13():1228575. PubMed ID: 37554164
    [Abstract] [Full Text] [Related]

  • 9. Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
    Nilica B, Waitz D, Stevanovic V, Uprimny C, Kendler D, Buxbaum S, Warwitz B, Gerardo L, Henninger B, Virgolini I, Rodrigues M.
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1585-92. PubMed ID: 26922350
    [Abstract] [Full Text] [Related]

  • 10. 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.
    Zhang J, Zhu Z, Zhong D, Dang Y, Xing H, Du Y, Jing H, Qiao Z, Xing X, Zhuang H, Li F.
    Clin Nucl Med; 2015 Aug; 40(8):642-6. PubMed ID: 26053726
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis.
    Agrawal K, Padhy BM, Meher BR, Mohanty RR.
    Nucl Med Commun; 2021 Jun 01; 42(6):646-655. PubMed ID: 33625187
    [Abstract] [Full Text] [Related]

  • 12. Performance of 68Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and 18F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis.
    Jiang Y, Hou G, Cheng W.
    Nucl Med Commun; 2020 Apr 01; 41(4):370-376. PubMed ID: 32000173
    [Abstract] [Full Text] [Related]

  • 13. 68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.
    El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT.
    J Clin Endocrinol Metab; 2016 Oct 01; 101(10):3575-3581. PubMed ID: 27533306
    [Abstract] [Full Text] [Related]

  • 14. 68Ga-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with 18F-DOPA PET/CT and 123I-MIBG SPECT/CT.
    Kroiss AS, Uprimny C, Shulkin BL, Gruber L, Frech A, Url C, Riechelmann H, Sprinzl GM, Thomé C, Treglia G, Kjaer A, Fraedrich G, Virgolini IJ.
    Nucl Med Biol; 2019 Apr 01; 71():47-53. PubMed ID: 31152973
    [Abstract] [Full Text] [Related]

  • 15. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
    Bhavani N, Reena Asirvatham A, Kallur K, Menon AS, Pavithran PV, Nair V, Vasukutty JR, Menon U, Kumar H.
    Clin Endocrinol (Oxf); 2016 Jan 01; 84(1):134-40. PubMed ID: 25996566
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of 68Ga-DOTA-TATE PET/CT imaging for tumor- induced osteomalacia.
    Zhang Y, Zhang X, Zhang W, Huang Z, Chen Y.
    Ann Palliat Med; 2020 Sep 01; 9(5):3350-3356. PubMed ID: 32921125
    [Abstract] [Full Text] [Related]

  • 17. Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET/CT vs somatostatin receptor-based functional scans: a series of nine patients.
    Jadhav S, Kasaliwal R, Lele V, Rangarajan V, Chandra P, Shah H, Malhotra G, Jagtap VS, Budyal S, Lila AR, Bandgar T, Shah NS.
    Clin Endocrinol (Oxf); 2014 Jul 01; 81(1):31-7. PubMed ID: 24528172
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance and impact on patient management of [68Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut.
    Delabie P, Baudin É, Hentic O, Afchain P, Rusu T, Montravers F.
    Medicine (Baltimore); 2022 Nov 25; 101(47):e31512. PubMed ID: 36451394
    [Abstract] [Full Text] [Related]

  • 19. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
    Singh D, Chopra A, Ravina M, Kongara S, Bhatia E, Kumar N, Gupta S, Yadav S, Dabadghao P, Yadav R, Dube V, Kumar U, Dixit M, Gambhir S.
    Br J Radiol; 2017 Apr 25; 90(1072):20160811. PubMed ID: 28181822
    [Abstract] [Full Text] [Related]

  • 20. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
    Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A.
    Clin Nucl Med; 2015 Jan 25; 40(1):e6-e10. PubMed ID: 24999675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.